We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$27.3M
Cap. Flow
-$34.7M
Cap. Flow %
-23.28%
Top 10 Hldgs %
25.17%
Holding
298
New
63
Increased
40
Reduced
80
Closed
82

Top Buys

Rank Stock Value
1
ABVX
Abivax
ABVX
+$2.73M
2
PFE icon
Pfizer
PFE
+$2.42M
3
ARGX icon
argenx
ARGX
+$2.33M
4
VYNE icon
VYNE Therapeutics
VYNE
+$2.08M
5
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$1.95M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$3.38M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.95M
3
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.75M
4
TSVT
2seventy bio
TSVT
+$2.58M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Real Estate 11.94%
3 Financials 4.93%
4 Consumer Discretionary 2.41%
5 Industrials 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
251
DELISTED
Hess
HES
– –
-315
Closed -$48.2K
HPE icon
252
Hewlett Packard
HPE
$63.2B
– –
-7,249
Closed -$126K
HYD icon
253
VanEck High Yield Muni ETF
HYD
$4.44B
– –
-7,000
Closed -$343K
HYMB icon
254
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.07B
– –
-13,000
Closed -$310K
IMO icon
255
Imperial Oil
IMO
$62.1B
– –
-1,671
Closed -$103K
INSM icon
256
Insmed
INSM
$23.2B
– –
-80,000
Closed -$2.02M
IWD icon
257
iShares Russell 1000 Value ETF
IWD
$82B
– –
-14,193
Closed -$2.15M
JKHY icon
258
Jack Henry & Associates
JKHY
$10.7B
– –
-1,344
Closed -$203K
JMST icon
259
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.11B
– –
-6,000
Closed -$303K
JNJ icon
260
Johnson & Johnson
JNJ
$635B
– –
-1,426
Closed -$222K
KNSA icon
261
Kiniksa Pharmaceuticals
KNSA
$4.83B
– –
-110,000
Closed -$1.91M
MOS icon
262
The Mosaic Company
MOS
$7.09B
– –
-4,255
Closed -$151K
MPC icon
263
Marathon Petroleum
MPC
$90.3B
– –
-1,862
Closed -$282K
NBIX icon
264
Neurocrine Biosciences
NBIX
$17.7B
– –
-30,000
Closed -$3.38M
OVV icon
265
Ovintiv
OVV
$17.5B
– –
-1,708
Closed -$81.3K
OXY icon
266
Occidental Petroleum
OXY
$57B
– –
-3,141
Closed -$204K
PFG icon
267
Principal Financial Group
PFG
$23.6B
– –
-1,308
Closed -$94.3K
PGR icon
268
Progressive
PGR
$124B
– –
-1,880
Closed -$262K
PHAT icon
269
Phathom Pharmaceuticals
PHAT
$912M
– –
-160,000
Closed -$1.66M
PRCT icon
270
Procept Biorobotics
PRCT
$950M
– –
-30,000
Closed -$984K
PSX icon
271
Phillips 66
PSX
$82.9B
– –
-1,999
Closed -$240K
RARE icon
272
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-30,000
Closed -$1.07M
RPV icon
273
Invesco S&P 500 Pure Value ETF
RPV
$1.61B
– –
-29,285
Closed -$2.15M
SCPH
274
DELISTED
scPharmaceuticals
SCPH
– –
-125,000
Closed -$890K
TER icon
275
Teradyne
TER
$54.8B
– –
-7,500
Closed -$753K
8 9 10
11
12

Similar funds

AIS
Advocate Investing Services Woodbine, Maryland $118M AUM
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $118M AUM 64.91% 1-Year Est. Return
OIM
Oceanic Investment Management Douglas, Isle Of Man $118M AUM
TIP
Tandem Investment Partners Bordentown, New Jersey $118M AUM 15.76% 1-Year Est. Return
RCG
Ridge Creek Global Strongsville, Ohio $118M AUM
CWM
Capstone Wealth Management Billings, Montana $118M AUM
SPW
Stillwater Private Wealth Glen Mills, Pennsylvania $118M AUM
WLC
Walnut Level Capital Denver, Colorado $118M AUM 59.12% 1-Year Est. Return

AlphaCentric Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, AlphaCentric Advisors held 298 positions worth $149M, down 16% from $176M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

AlphaCentric Advisors withdrew a net $34.7M in Q4 2023, closing 82 positions and reducing 80 holdings. Its most notable exit was Neurocrine Biosciences, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 62% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Abivax worth $2.86M.

  • AlphaCentric Advisors's largest Q4 2023 buy was Abivax: 267,500 shares worth $2.86M.
  • AlphaCentric Advisors added most to argenx in Q4 2023, an estimated $2.33M increase.
  • AlphaCentric Advisors's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.75M.
  • AlphaCentric Advisors fully exited Neurocrine Biosciences in Q4 2023, selling an estimated $3.38M.
  • AlphaCentric Advisors's ten largest holdings make up 25% of its $149M portfolio in Q4 2023.
  • AlphaCentric Advisors opened 63 new positions and closed 82 in Q4 2023.
  • AlphaCentric Advisors's portfolio value fell 16% quarter-over-quarter to $149M.

Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.